← Open Payments lookup

MELISSA GUILBEAU: Open Payments

NPI 1952407728 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$32,311 in 220 payments from 21 companies in 2025. Trend: 2023 $45,705 · 2024 $30,422 · 2025 $32,311

Speaker / faculty: $27,000Food & beverage: $3,959Travel & lodging: $1,240Education: $111
CompanyPaymentsAmount
ABBVIE INC.69$29,120
Braeburn Inc.19$445
Axsome Therapeutics, Inc.7$334
Otsuka America Pharmaceutical, Inc.21$313
E.R. Squibb & Sons, L.L.C.8$305
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$297
Teva Pharmaceuticals USA, Inc.9$260
Alkermes, Inc.16$229
Neurocrine BioSciences, Inc.14$206
Indivior Inc.5$159

Products named: VRAYLAR, BRIXADI, Auvelity, COBENFY, CAPLYTA, INGREZZA, REXULTI, ARISTADA.

Industry payments across LA — which companies pay providers there.